Neurology Flashcards
Features of migraine
Severe, unilateral, throbbing headache
Typically lasts 4-72 hours
Associated with nausea, photonics and phonophobia
1/3 of patients experience aura (visual (transient hemianoptic disturbance or a spreading scintillating scotoma), progressive, last 5-60 min)
Migraine: epidemiology (gender)
3 times more common in women
Common triggers for a migraine attack
Chocolate / Cheese / Citrus fruits
Combined Oral Contraceptive Pill / Hormonal (menstruation)
Alcohol (especially red wine)
Lights
Lack of food / dehydration / Tiredness / Stress
Migraine diagnostic criteria (5)
- At least FIVE attacks fulfilling the criteria
- Two classic features: unilateral, pulsating, moderate-severe pain, aggravation by routine physical activity
- At least ONE: nausea/vomiting and/or photophobia/phonophobia
- Lasts 4-72 hours
- Not attributed to another disorder
General rule of migraine acute vs prophylactic management
5-HT receptor agonists (e.g. triptans) are used in acute treatment, 5-HT receptor antagonists are used in prophylaxis (e.g. propranolol, amitriptyline)
1st line treatment of acute migraine
Oral triptan + NSAID
Or
Oral triptan + paracetamol
Antiemetics e.g. metoclopramide for vomiting - can lead to EPSEs
Aged 12-17: consider nasal triptans
Options for medical prophylaxis of migraines
Propranolol
Amitriptyline
Topiramate (AVOID in women of childbearing age)
Menstrual migraine treatment
Frovatriptan or zolmitriptan 2.5mg BD around menstruation
‘Complementary medicine’ option for migraine prophylaxis
Acupuncture
Vitamin supplement useful in migraine prophylaxis
Vitamin B2 (riboflavin)
Hemiplegic migraine features
can mimic stroke - act fast
Typical migraine symptoms
Sudden or gradual onset
Hemiplegia (unilateral weakness of limbs)
Ataxia
Changes in consciousness
Contraception contraindicated in patients with migraine with aura
COC (due to increased risk of stroke)
1st line pain relief migraine in pregnancy
1st line: Paracetamol 1g
2nd line: NSAIDs can be used in first and second trimester, avoid aspirin and opioids e.g. codeine
Red flag aura symptoms
Motor weakness
Double vision
Visual symptoms affecting only one eye
Poor balance
Decreased level of consciousness
Most common cause of primary headache in children
Migraine without aura
ABCD2 score
Risk of stroke after a suspected TIA
Age > 60
BP > 140/90
Clinical features
Duration
Diabetes diagnosis
TIA definiton
A transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischaemia, without acute infarction
(No longer time based definition)
Clinical features of TIA
Stroke symptoms that typically resolve within 1 hour
- Unilateral weakness or sensory loss
- Aphasia or dysarthria
- Ataxia, vertigo
- Visual problems
Immediate management of TIA
Aspirin 300mg daily (unless contraindicated or already on aspirin)
Referral for specialist assessment within 24 hours if TIA occurred in last 7 days
If > 7 days ago, refer for assessment within 7 days
Initial management of patient with suspected TIA who is on warfarin/a DOAC or has a bleeding disorder
Admit immediately for imaging to exclude haemorrhage
Aspirin 300mg is contraindicated
Investigations to assess the underlying cause of TIA or stroke (2)
All patients should have an urgent carotid doppler to assess for carotid artery stenosis
ECG to assess for atrial fibrillation
Surgical intervention where there is significant carotid artery stenosis (> 70%)
Carotid endarterectomy
Note: only available if the patient is not severely disabled
Preferred modality in patients with suspected TIA who require brain imaging
MRI brain with diffusion-weighted imaging
1st and 2nd line secondary prevention for TIA or stroke
1st: Clopidogrel 75mg once daily + Atorvastatin 20-80mg daily
2nd: Aspirin + dipyridamole (anti-platelet) + Atorvastatin 20-80mg daily
Crescendo TIA
Two or more TIAs within a week - indicate a high risk of stroke
4 pathological causes of disruption of blood supply to the brain
Thrombus or embolus
Atherosclerosis
Shock
Vasculitis
1st line radiological investigation for suspected stroke
+ signs for ischaemic vs haemorrhagic
Non-contrast CT head scan
Ischaemic signs: hyperdense artery corresponding with the responsible arterial clot
Haemorrhagic signs: hyperdense material (blood) surrounded by low density (oedema)
ROSIER score
Recognition of stroke in the ER
Management of stroke (4)
Exclude hypoglycaemia
Immediate CT scan
Aspirin 300mg daily for 2 weeks (once haemorrhage is excluded)
Admission to specialist stroke centre
Indications for IV thrombolysis with alteplase in stroke management
Within 4.5 hours of onset of stroke symptoms
Haemorrhage has been definitely excluded
Indication for thrombectomy in the management of ischaemic stroke
Within 6-24 hours
Offer to patients where there is confirmed occlusion of the proximal anterior circulation and if there is potential to salvage brain tissue (scans show limited infarct core volume)
Indication for thrombectomy with IV thrombolysis
Within 4.5 hours
Confirmed occlusion of proximal posterior circulation (basilar or PCA) and potential to salvage brain tissue (i.e. scans show limited infarct core volume)
Parkinson’s triad
ASYMMETRICAL:
Bradykinesia
Tremor
Rigidity
Bradykinesia presentation in Parkinson’s
Movement gets slower and smaller:
- Short, shuffling steps with reduced arm swinging
- Difficulty in initiating movement e.g. standing to walking
Tremor presentation in Parkinson’s
Most marked at REST
3-5 Hz
Worse when stressed or tired
Improves with voluntary movement
Typically ‘pill-rolling’, i.e. thumb and index finger
Rigidity presentation in Parkinson’s
‘Cogwheel’ due to superimposed tremor / resistance to passive movement of joint
Psychiatric features in Parkinson’s (4)
Depression (most common - 40%)
Dementia
Psychosis
Sleep disturbances
What can autonomic dysfunction in Parkinson’s cause
Postural hypotension
Parkinsonism vs Parkinson’s
Parkinsonism:
Motor symptoms are generally RAPID onset and BILATERAL
Rigidity and rest tremor are UNCOMMON
Who can diagnose Parkinson’s disease
A specialist with expertise in movement disorders
1st line treatment for Parkinson’s where the motor symptoms are affecting the patients QOL
Levodopa
(Co-carelodopa/Co-beneldopa)
Treatment for Parkinson’s where motor symptoms are not affecting patients QOL
Dopamine agonist (non-ergot derived)
Levodopa
Monoamine Oxidase B inhibitor
Which antiparkinson drug is associated with the greatest improvement in symptoms and ADLs but has more motor complications
Levodopa
Which antiparkinsonian medication has the highest chance of inhibition disorders
Dopamine agonist therapy
What is levodopa usually combined with to prevent peripheral metabolism
Peripheral decarboxylase inhibitors e.g. carbidopa or benserazide
Types of dyskinesias (side effect of levodopa at peak dose)
Dystonia
Chorea
Athetosis
Adverse effects of levodopa (5)
Dry mouth
Orthostatic hypotension
Palpitations, Psychosis
Anorexia
2 phenomenons regarding levodopa use
End-of-dose wearing off: symptoms worsen towards end of dosage interval resulting in decline of motor activity
On-off phenomenon: normal function during ‘on’ period, weakness and restricted mobility during ‘off’ period
Levodopa is an example of a critical medicine, what does this mean?
Must not be acutely stopped
What can be given as a rescue medicine if levodopa cannot be given orally
Dopamine agonist patch
- to prevent acute dystonia
Mechanism of action of COMT inhibitors
COMT enzyme metabolises levodopa in both the body and brain
COMT inhibitors extend the effective duration of levodopa by slowing down the breakdown in the brain
What kind of drug is entacapone
COMT inhibitor
Indication for the use of dopamine receptor agonists and Monoamine oxidase-B inhibitors in Parkinson’s
Less effective than levodopa in reducing symptoms, therefore used to delay the use of levodopa and then used in combination with levodopa to reduce the dose of levodopa required
Examples of ergot-derived dopamine receptor agonists (2nd line to non ergot-derived)
Bromocriptine
Carbergoline
Complications of the use of ergot-derived dopamine receptor agonists e.g. bromocriptine
Pulmonary, retroperitoneal and cardiac fibrosis
Example of MAO-B inhibitor
Selegiline
Rasagiline
Action of Monoamine oxidase enzymes
Break down neurotransmitters such as dopamine, serotonin and adrenaline
MAO-B is specific to dopamine
Prognosis of MND
Poor - 50% of patients die within 3 years
Riluzole mechanism in MND
prevents stimulation of glutamate receptors = slows progression/prognosis of disease
only licensed medication to treat MND
ALS presentation
Age around 60 / Male
Asymmetric progressive weakness (limbs, trunk, face, speech)
Mixture of lower motor neuron and upper motor neuron signs
Absence of sensory signs
What motor features are preserved in MND
External ocular muscles
Cerebellar signs
Abdominal reflexes
Diagnosis of MND
Clinical diagnosis based on presentation and exclusion of other neuropathies (nerve conduction studies are normal)
Lower motor neurone signs
Muscle wasting
Reduced tone
Fasciculations (twitches in the muscles)
Reduced reflexes
Upper motor neurone signs
Increased tone or spasticity
Brisk reflexes
Upgoing plantar reflex
Which muscles are primarily affected in progressive bulbar palsy
Muscles of talking and swallowing (the bulbar muscles)
Most common cause of meningitis in neonates (0-3 months)
Group B Streptococcus (usually contracted during birth from GBS bacteria that live harmlessly in the mothers vagina)
Most common cause of bacterial meningitis in children and adults
Streptococcus pneumoniae (pneumococcus)
Neisseria meningitidis (gram negative meningococcus)
Causal organisms of meningitis in: > 60 years
Streptococcus pneumoniae
Neisseria meningitidis
Listeria monocytogenes
Causal organisms of meningitis in: immunosuppressed
Listeria monocytogenes
Explain the lumbar puncture results of a bacterial sample
Appearance: cloudy (proteins)
Protein: high (bacteria release proteins)
Glucose: low (bacteria eat up the glucose) - typically < 1/2 plasma glucose
WCC: high (immune system releases neutrophils in response to bacteria)
What level is a lumbar puncture needle inserted
L3-L4
Explain the lumbar puncture results of a viral sample
Appearance: clear
Protein: mildly raised/normal (viruses may release a small amount of protein)
Glucose: normal (viruses don’t use glucose: 60-80% of plasma glucose present)
WCC: high (immune system releases lymphocytes in response to viruses)
Complications of meningitis
Hearing loss
Seizures and epilepsy
Cognitive impairment and learning disability
Memory loss
Cerebral palsy, with focal neurological deficits such as limb weakness or spasticity
Most common causes of viral meningitis
Herpes simplex virus (HSV)
Enterovirus
Varicella zoster virus (VZV)
Management of viral meningitis
Tends to be milder than bacterial and often only requires supportive treatment
Acyclovir can be used to treat HSV or VZV
Post exposure prophylaxis for close prolonged contact of bacterial meningitis 7 days before onset
Single dose of ORAL ciprOflOxacin
(Rifampicin can be used but ciprofloxacin is preferred)
Management of suspected meningococcal disease in a primary care setting
Urgent stat injection (IM or IV) of benzylpenicillin
+ dexamethasone to reduce complications
Red flag of a non-blanching rash in children accompanied by headache, fever, neck stiffness
Meningococcal septicaemia - indicates that the infection has caused DIC and subcutaneous haemorrhages
Typical symptoms of meningitis
Fever
Neck stiffness
Vomiting
Headache
Photophobia
Altered conciousness
Seizures
2 special tests to look for meningeal irritation
Kernigs test
Brudzinskis test
Antibiotic management of bacterial meningitis
Over 3 months: IV cefotaxime or ceftriaxone
Under 3 months: IV cefotaxime + amoxicillin (to cover listeria)
Which medication is given in meningitis management to reduce the frequency and severity of hearing loss and neurological damage
Dexamethasone - 4 times daily for 4 days to children over 3 months
Circumstances where lumbar puncture should be delayed in the investigation of meningitis
Signs of severe sepsis or a rapidly evolving rash
Severe respiratory/cardiac compromise
Significant bleeding risk
Signs of raised intracranial pressure
4 signs of raised intracranial pressure
Focal neurological signs
Papilloedema
Continuous or uncontrolled seizures
GCS <12
Who should not receive IV dexamethasone in the management of meningitis
Septic shock
Meningococcal septicaemia
Immunocompromised
When would neuroimaging be indicated in suspected bacterial meningitis
Raised ICP - otherwise not normally indicated
Most common cause of foot drop
Common peroneal nerve lesion causing weakness of the foot dorsiflexor muscles
Risk of having a stroke with AF score
CHADSVAS
Congestive heart failure
Hypertension
Aged 75 years or older
Diabetes mellitus
Stroke (previous)
Vascular disease
Age 65-74
Sexual category (female)
Total anterior circulation stroke (TACS) criteria
Bamford classification of ischaemic stroke
Stroke affecting both the MCA and ACA
Diagnosis requires all 3 of the following:
Unilateral weakness of face, arm and leg
Homonymous hemianopia
Higher cerebral dysfunction e.g. dysphasia
Posterior circulation stroke key symptoms
Dizziness
Diplopia
Dysarthria
Dysphagia
Dystaxia
what are Lewy Bodies
alpha synuclein cytoplasmic inclusions
seen in LBD, Parkinson’s + Alzheimer’s
Lilluptian bodies
Lewy body dementia associated visual hallucinations, classically of small creatures/children/figures
Lewy body dementia vs parkinson’s disease dementia
Lewy Body Dementia: starts at the top and eventually descends to the substantia nigra / dementia and movement disorder develop within a year of each other
Parkinson’s Disease Dementia: inclusions affect the substantia nigra (to cause the movement disorder) before ascending to involve the paralimbic and neocortical areas to result in dementia / movement disorder and dementia develop a year apart
Fronto-temporal dementia features
Onset before 65
Insidious onset
cognitive impairment
personality change
repetitive checking behaviour
disinhibition
Memory loss is a late feature
Constructional apraxia i.e. failure to draw interlocking pentagons may be a key feature in the early stages
3 variants of frontotemporal dementia
Behavioural variant (60%), characterised by loss of social skills, personal conduct awareness, disinhibition, and repetitive behaviour
Semantic dementia (20%), characterised by an inability to remember words for things, calling them ‘thingy’
Progressive non fluent aphasia (20%), where the patient can’t verbalise; their speech is laboured and difficult
Risk factor for frontotemporal dementia
repetitive head injury
Pick’s disease
one cause of FTD / diagnosed on post-mortem where “Pick’s bodies” (accumulations of TAU protein that stain with silver) are found in the neurons
Second most common cause of dementia
Vascular dementia
Dementia assessment tools recommended by NICE for the non-specialist setting
10-point cognitive screener (10-CS)
6-Item cognitive impairment test (6CIT)
AMTS and MMSE are also widely used but not recommended by NICE
Primary care blood screening for dementia
FBC, U&E, LFTs, calcium, glucose, ESR/CRP, TFTs, vitamin B12 and folate levels
Secondary care primary investigation for dementia
Neuroimaging (exclude other reversible conditions e.g. subdural haematoma) and provide aetiological information
Dementia most likely to present with fluctuating cognition
Lewy Body Dementia
Which medication should be avoided in LBD
Neuroleptics may cause irreversible parkinsonism
When should antipsychotics be used in Alzheimer’s patients
patients at risk of harming themselves or others, or when the agitation, hallucinations or delusions are causing them severe distress
antipsychotics in AD are associated with a sig. risk of increased mortality
Middle cerebral artery presentation (4)
Contralateral hemiparesis and sensory loss
Upper extremity > lower
Contralateral homonymous hemianopia
Aphasia
Anterior cerebral artery key presentation
Contralateral hemiparesis and sensory loss
Lower extremity > Upper
Horner’s syndrome features
Unilateral
Anhidrosis (absence of sweating of the face)
Miosis (constricted pupil)
Ptosis (drooping eyelid)
Enophthalmos (inset eye)
Which lung cancer tumour can lead to Horner’s syndrome
Pancoast (apical) tumour compressing the sympathetic chain
Pharmacological medication in Alzheimer’s
1st line:
Acetylcholinesterase inhibitors (donepezil, galantamine and rivastigmine)
Severe (as an add on) or if Acetylcholinesterase i are contraindicated: Memantine (NMDA receptor antagonist)
NICE does not recommend antidepressants for mild to moderate depression in dementia patients
Trigeminal neuralgia features
unilateral
brief electric shock-like pains, abrupt in onset and termination, limited to one or more divisions of the trigeminal nerve
the pain is commonly evoked by light touch, including washing, shaving, smoking, talking, and brushing the teeth (trigger factors)
Red flag signs in trigeminal neuralgia
Onset before 40
Family history of MS
Optic neuritis
Sensory changes
Deafness
Bilateral pain
refer to neurology
1st line treatment trigeminal neuralgia
Carbamazepine
if contraindicated or not tolerated, refer to neurology
Mixed dementia (2 most common types)
AD and VD
Non-ergot derived dopamine agonists examples
Ropinirole
Rotigotine
Major non-modifiable risk factor for TIA
Age - risk doubles every decade after 55
Huntington’s disease genetic features (4)
- Autosomal dominant
- Trinucleotide repeat disorder (repeat CAG expansion)
- Defect in huntingtin gene on chromosome 4
- Anticipation